Eleven of these patients (9%) were associated with tumors: 8 lung cancers (2 with LGI1 antibodies, 7 with GABAB antibodies), 1 colorectal adenoma (1 with LGI1 antibodies), 1 ovarian teratoma (1 with NMDAR antibodies), and 1 thymoma (1 with LGI1 antibodies). Here, LGI1 is linked to lung cancer.